| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/26/2001 | WO2000078204A3 Methods for remote characterization of an odor |
| 07/26/2001 | WO2000073776A3 Semiconductor gas sensor, gas sensor system and method of gas analysis |
| 07/26/2001 | WO2000071741A9 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 07/26/2001 | WO2000070341A3 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 07/26/2001 | WO2000069915A3 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES |
| 07/26/2001 | WO2000066995A3 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification |
| 07/26/2001 | WO2000066156A8 Death domain containing receptor 5 |
| 07/26/2001 | WO2000065341A9 Eosinophil degranulating conditions |
| 07/26/2001 | WO2000059547A3 Method of detecting endometriosis |
| 07/26/2001 | WO2000055194A9 Tuberculosis antigens and methods of use therefor |
| 07/26/2001 | WO2000046597A9 Dissolution test sample holder |
| 07/26/2001 | WO2000045176A3 METHOD OF IDENTIFYING N-TERMINAL proBNP |
| 07/26/2001 | WO2000045169A9 Methods for enhancing binding interactions between members of specific binding pairs |
| 07/26/2001 | WO2000044281A9 Apparatus and method for detecting anomalies in human tissue |
| 07/26/2001 | WO2000043791A3 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases |
| 07/26/2001 | WO2000037683A9 HIGH THROUGHPUT ASSAY SYSTEM FOR MONITORING ESTs |
| 07/26/2001 | WO2000017361A3 Interferon-epsilon |
| 07/26/2001 | WO2000015178A3 Computer implemented pharmacokinetics method and program |
| 07/26/2001 | WO1999064040A8 Novel polyene macrolide compounds and uses |
| 07/26/2001 | US20010009957 Invaplex from gram negative bacteria, method of purification and methods of use |
| 07/26/2001 | US20010009956 Method and partitioning blood using polyesters |
| 07/26/2001 | US20010009905 Adipocyte Complement-Related Protein encoded polypeptides, used in therapy and diagnosis, cell proliferation, cell death, energy homestasis; treatment of cancers, obesity, diabetes, heart disease, immunity |
| 07/26/2001 | US20010009900 Breast cancer, increase insulin receptor phosphorylation in Type II diabetics |
| 07/26/2001 | US20010009774 Comprising molecular adhesive layer chemically adsorbed to surface of solid state element, three dimensional layer of hydrophilic polymer bonded to molecular adhesive layer, bioelement immobilized in layer by adhesive |
| 07/26/2001 | US20010009773 Procedure and apparatus for the optimization of reactive gas mixtures |
| 07/26/2001 | US20010009766 Dna encoding galanin galr3 receptors and uses thereof |
| 07/26/2001 | US20010009765 Contacting immobilized phase comprising two immunity substances capable of specifically binding with two kinds of assay target substances selected from verotoxin-producing Escherichia coli, verotoxin and human hemoglobin |
| 07/26/2001 | US20010009764 Endothelial-derived toxic factor |
| 07/26/2001 | US20010009763 Array of a plurality of particles having probes, respectively, fixed thereon, said probes being capable of binding to different target substances to be examined, respectively |
| 07/26/2001 | US20010009760 Reducing background signals in nucleic acid hybridization assays by using an oligonucleotide labelled with a quenchable dipyrrolometheneboron difluoride dye |
| 07/26/2001 | US20010009757 A closed, sterile continuous flow process by selectively binding a specific cell population to a particle having a selective binding site to form a conjugate; separating by continuous flow centrifuging; sedimentation; immunoaffinity |
| 07/26/2001 | US20010009670 Parenterally administering large liposomes comprised of phospholipids substantially free of sterol, where the liposomes pick-up cholesterol |
| 07/26/2001 | US20010009667 Method of detecting nucleic acid encoding a retrovirus using polymerase chain reaction (pcr) |
| 07/26/2001 | US20010009665 Treating a cancer patient by administering the antibodies or fragments which are cytotoxic against cancer cells but benign to noncancerous cells, in admixture with a pharmaceutical adjuvant |
| 07/26/2001 | DE10050489A1 Electrical decontamination and sterilization of water employs low voltage signal generator, with automatic adjustment as a function of water conductivity |
| 07/26/2001 | DE10002920A1 Device for contacting biological material immobilized on surface with solution of second biological material, especially hybridization of DNA samples, comprises a cavity receiving solution with cover which has seal around its edges |
| 07/26/2001 | DE10002546A1 Arrangement for testing lubricants, especially those used in CVT linkages, has an arrangement of test bodies that enables a rotating and sliding motion to be created |
| 07/26/2001 | DE10000651A1 Identifying inhibitors and activators of eukaryotic potassium channels, for use as pharmaceuticals, comprises using yeast cells that express heterologous, but no endogenous, potassium channels |
| 07/26/2001 | CA2479511A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2479498A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2412536A1 Method for isolating proteins or protein and nucleic acid associations, and resulting complexes of particles and proteins, reagents and applications |
| 07/26/2001 | CA2401786A1 Contacting device |
| 07/26/2001 | CA2398808A1 Biocidal molecules, macromolecular targets and methods of production and use |
| 07/26/2001 | CA2398710A1 Egg specific surface proteins |
| 07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
| 07/26/2001 | CA2398690A1 Barcoded synthetic lethal screening to identify drug targets |
| 07/26/2001 | CA2398256A1 Methods for detecting cancer of the central nervous system |
| 07/26/2001 | CA2398058A1 Gene chip for neonate screening |
| 07/26/2001 | CA2398010A1 An in vivo screen using chemical inducers of dimerization |
| 07/26/2001 | CA2397946A1 Lipid metabolism enzymes |
| 07/26/2001 | CA2397931A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
| 07/26/2001 | CA2397919A1 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| 07/26/2001 | CA2397901A1 Cbp86, a sperm specific protein |
| 07/26/2001 | CA2397900A1 Method for quantitating creatinine discharged in urine, method for measuring urine component and apparatus therefor |
| 07/26/2001 | CA2397883A1 Methods of and apparatus for separating and detecting nucleic acid |
| 07/26/2001 | CA2397838A1 Sperm specific proteins |
| 07/26/2001 | CA2397774A1 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | CA2397656A1 Integrated support, integrated minute vessels and permeable membrane, and method of making and using the same |
| 07/26/2001 | CA2397646A1 Mouse model for rheumatoid arthritis |
| 07/26/2001 | CA2397637A1 Method for detection or determination if environmental hormones |
| 07/26/2001 | CA2397617A1 Novel human nucleic acid molecules and polypeptides encoding cation channels |
| 07/26/2001 | CA2397603A1 Non-invasive in-vivo tissue classification using near-infrared measurements |
| 07/26/2001 | CA2397133A1 Diet and activity monitoring device |
| 07/26/2001 | CA2397059A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes |
| 07/26/2001 | CA2396935A1 Phosphatases |
| 07/26/2001 | CA2396810A1 Sensitive, multiplexed diagnostic assays for protein analysis |
| 07/26/2001 | CA2395770A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 07/26/2001 | CA2395749A1 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
| 07/26/2001 | CA2395736A1 Novel nucleic acids and polypeptides |
| 07/26/2001 | CA2395731A1 Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2394753A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2365610A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2332208A1 Pharmacophore models for, methods of screening for, and identification of the cytochrome p-450 inhibitory potency of neurokinin-1 receptor antagonists |
| 07/25/2001 | EP1118860A1 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| 07/25/2001 | EP1118858A2 Assay method |
| 07/25/2001 | EP1118857A2 Method for on-line measurement of heat content of fuel in a combustion turbine system |
| 07/25/2001 | EP1118856A1 Sample component analysis system and sensor chip and sensor pack used for the system |
| 07/25/2001 | EP1118855A2 Method for predicting flammability limits of complex mixtures |
| 07/25/2001 | EP1118851A2 A device for measuring the compression that can be exerted by a hosiery article |
| 07/25/2001 | EP1118681A1 Method for controlling the release of granules |
| 07/25/2001 | EP1118680A1 Method for the diagnosis of polymorphisms in the human PDH E1alpha gene |
| 07/25/2001 | EP1118661A1 T cell receptor libraries |
| 07/25/2001 | EP1118622A1 Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies |
| 07/25/2001 | EP1118620A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/25/2001 | EP1118619A1 Method to identify agents active against HCV by using the structure coordinates of hepatitis C virus protease |
| 07/25/2001 | EP1118618A1 Monitor protein for measuring phosphorylation of protein |
| 07/25/2001 | EP1118377A2 Large pore synthetic polymer membranes |
| 07/25/2001 | EP1118267A1 A method and system for verification of fertilization of poultry eggs |
| 07/25/2001 | EP1118072A1 Method for producing a component and corresponding component |
| 07/25/2001 | EP1118001A1 Method to determine a predisposition to leptin treatment |
| 07/25/2001 | EP1118000A1 Determining resistance to treatment for hepatitis c virus |
| 07/25/2001 | EP1117999A1 Characterising polypeptides through cleavage and mass spectrometry |
| 07/25/2001 | EP1117998A1 Egfr 37 kda fragment as cancer marker |
| 07/25/2001 | EP1117997A1 Assay using porosity-reduction to inhibit migration |
| 07/25/2001 | EP1117996A2 Method and device for producing and/or analyzing biochemical reaction supporting materials |
| 07/25/2001 | EP1117995A1 Method and apparatus for determining and evaluating bacterial populations |
| 07/25/2001 | EP1117994A1 Device and method for measurement of process parameters for controlling of metallurgical processes |
| 07/25/2001 | EP1117991A1 Conductive organic sensors, arrays and methods of use |
| 07/25/2001 | EP1117989A1 Method for the photometric analysis of test elements |